Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000176

Chief Medical Officer acquired 13,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
TRABER PETER G Chief Medical Officer 2021-12-08 Grant or award +13,750 168,464 D
Loading xslF345X03/wf-form4_163917405252050.xml…